Brokerages Set Henry Schein, Inc. (NASDAQ:HSIC) PT at $79.40

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has earned an average recommendation of "Moderate Buy" from the twelve research firms that are covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $79.40.

HSIC has been the topic of several recent analyst reports. Barrington Research reiterated an "outperform" rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and boosted their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Evercore ISI raised their target price on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Finally, Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target on the stock.

Henry Schein Price Performance

Shares of Henry Schein stock traded down $1.39 during mid-day trading on Friday, reaching $69.67. 1,096,036 shares of the stock traded hands, compared to its average volume of 1,009,656. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The business has a 50-day moving average of $72.14 and a 200 day moving average of $70.43. The stock has a market capitalization of $8.69 billion, a PE ratio of 28.67, a PEG ratio of 2.30 and a beta of 0.89. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the prior year, the company earned $1.32 EPS. Henry Schein's revenue was up .4% compared to the same quarter last year. On average, analysts predict that Henry Schein will post 4.78 EPS for the current year.

Insider Activity

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.14% of the company's stock.

Institutional Investors Weigh In On Henry Schein

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. ING Groep NV acquired a new stake in Henry Schein during the 3rd quarter worth approximately $63,226,000. Holocene Advisors LP acquired a new stake in shares of Henry Schein during the third quarter worth $58,319,000. Thompson Siegel & Walmsley LLC purchased a new position in Henry Schein in the 2nd quarter valued at $46,683,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Henry Schein in the 3rd quarter valued at $43,740,000. Finally, Southpoint Capital Advisors LP raised its position in Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock worth $189,540,000 after buying an additional 600,000 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.